Google counters DOJ antitrust charges by pointing out Bing exists

Google is offering one of its first formal responses to the Justice Department’s antitrust lawsuit over mobile search dominance, and it won’t surprise you to hear the company isn’t thrilled. Axios and the New York Times report that Google has rejecte...

Facebook reportedly offered to help create rivals to avoid antitrust lawsuits

Facebook was reportedly willing to go to great lengths to avoid antitrust lawsuits. Washington Post sources claim the company offered to license its code to others, helping them create rival social networks. This would have underscored Facebook’s “co...

Law bars ISPs from charging rental fees for a modem you own

Has your internet provider ever charged rental fees for a modem even after you bought one? You won’t have that pushback any longer. As Ars Technica notes, the Television Viewer Protection Act taking effect December 20th will ban ISPs and TV providers...

Google’s Fitbit acquisition finally gains EU approval

The EU has approved Google’s acquisition of Fitbit more than a year after it was announced, albeit with some catches. There are some “very limited horizontal overlaps” where Google could theoretically abuse its power, the EU said, and this would keep...

Fired Amazon worker gets a court hearing over retaliation claims

Amazon workers alleging retaliation over whistleblowing and labor organization will get at least one day in court. BuzzFeed News has learned that the National Labor Relations Board has granted former worker Courtney Bowden a hearing before an adminis...

India’s new ride hailing rules cap driver hours and limit surge pricing

India is bringing app-based ride hailing services under dedicated regulation for the first time, and it might just set an example for other countries. TechCrunch reports the country has instituted guidelines that set expectations for both drivers and...

FDA clears emergency use of lab-made antibodies to treat COVID-19

The FDA just cleared a medical advance that could play an important (if limited) role in treating COVID-19 patients. The administration has granted emergency use authorization for Regeneron’s lab-made monoclonal antibodies (a combo of casirivimab and...